Determination of Rapamycin in Whole Blood by HPLC
- 1 February 1997
- journal article
- Published by Wolters Kluwer Health in Therapeutic Drug Monitoring
- Vol. 19 (1) , 112-116
- https://doi.org/10.1097/00007691-199702000-00022
Abstract
Sirolimus (rapamycin, RAPA) is a natural fermentation product (macrolide antibiotic) that has demonstrated potent immunosuppressive activity. A reverse-phase high-performance liquid chromatographic (HPLC) method is described for analysis of the drug in whole blood. The samples are purified by using liquid-liquid extraction with butyl chloride/diethyl ether combined with reversed-phase solid-phase extraction. RAPA and internal standard were traced by UV-detection at 278 nm. Linear calibration curves with correlation coefficients > 0.999 were obtained (range, 1-50 ng/ml). Minimum detectable concentration was approximately 0.4 ng/ml and recovery approximately 45% for both RAPA and internal standard. Coefficient of variation (day to day) was 9.8% at 5 ng/ml (n = 6) and 5.6% at 40 ng/ml (n = 6). The chromatography requires < 10 min per sample. The assay has proved to be free of interference peaks from cyclosporine or tacrolimus. The method has been used to determine the whole blood concentrations in samples from healthy volunteers and renal transplant recipients receiving single and multiple doses of oral rapamycin.Keywords
This publication has 15 references indexed in Scilit:
- Blood Distribution Of RapamycinTransplantation, 1993
- BRIEF COMMUNICATIONTransplantation, 1993
- THE RELATIONSHIP OF BLOOD CONCENTRATIONS OF RAPAMYCIN AND CYCLOSPORINE TO SUPPRESSION OF ALLOGRAFT REJECTION IN A RABBIT HETEROTOPIC HEART TRANSPLANT MODEL1Transplantation, 1993
- Pharmacokinetics of RapamycinTherapeutic Drug Monitoring, 1992
- The isolation, synthesis and characterization of an isomeric form of rapamycinTetrahedron Letters, 1992
- Measurement of Rapamycin in Whole Blood Using Reverse-Phase High-Performance Liquid ChromatographyTherapeutic Drug Monitoring, 1992
- Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin ANature, 1991
- SYNERGISTIC INTERACTIONS OF CYCLOSPORINE AND RAPAMYCIN TO INHIBIT IMMUNE PERFORMANCES OF NORMAL HUMAN PERIPHERAL BLOOD LYMPHOCYTES IN VITROTransplantation, 1991
- RAPAMYCIN, A POTENT IMMUNOSUPPRESSIVE DRUG FOR VASCULARIZED HEART, KIDNEY, AND SMALL BOWEL TRANSPLANTATION IN THE RATTransplantation, 1991
- RAPAMYCIN FOR IMMUNOSUPPRESSION IN ORGAN ALLOGRAFTINGThe Lancet, 1989